Cargando…

Diffuse myocardial fibrosis associates with incident ventricular arrhythmia in implantable cardioverter defibrillator recipients

BACKGROUND: Diffuse myocardial fibrosis (DMF) quantified by extracellular volume (ECV) may represent a vulnerable phenotype and associate with life threatening ventricular arrhythmias more than focal myocardial fibrosis. This principle remains important because 1) risk stratification for implantable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olausson, Eric, Wertz, Jonathon, Fridman, Yaron, Bering, Patrick, Maanja, Maren, Niklasson, Louise, Wong, Timothy C, Fukui, Miho, Cavalcante, João L., Cater, George, Kellman, Peter, Bukhari, Syed, Miller, Christopher A., Saba, Samir, Ugander, Martin, Schelbert, Erik B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949189/ https://www.ncbi.nlm.nih.gov/pubmed/36824921 http://dx.doi.org/10.1101/2023.02.15.23285925

Ejemplares similares

An electrocardiography score predicts heart failure hospitalization or death beyond that of cardiovascular magnetic resonance imaging
por: Maanja, Maren, et al.
Publicado: (2022)

Diffuse Myocardial Fibrosis Reduces Electrocardiographic Voltage Measures of Left Ventricular Hypertrophy Independent of Left Ventricular Mass
por: Maanja, Maren, et al.
Publicado: (2017)

Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias
por: Römers, Hans, et al.
Publicado: (2022)

Performance of an automated external cardioverter defibrillator for inhospital ventricular malignant arrhythmia
por: Timerman, S, et al.
Publicado: (2003)

Genome-Wide Association of Implantable Cardioverter-Defibrillator Activation With Life-Threatening Arrhythmias
por: Murray, Sarah S., et al.
Publicado: (2012)

Benefit of a wearable cardioverter defibrillator for detection and therapy of arrhythmias in patients with myocarditis
por: Tscholl, Verena, et al.
Publicado: (2021)

Improved evaluation of left ventricular hypertrophy using the spatial QRS-T angle by electrocardiography
por: Maanja, Maren, et al.
Publicado: (2022)

Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring()
por: Galand, Vincent, et al.
Publicado: (2021)

Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator
por: Back, Steven H, et al.
Publicado: (2019)

Physical activity is reduced prior to ventricular arrhythmias in patients with a wearable cardioverter defibrillator
por: Burch, Ashley E., et al.
Publicado: (2019)

Impact of Myocardial Bridge on Life‐Threatening Ventricular Arrhythmia in Patients With Implantable Cardioverter Defibrillator
por: Okada, Kozo, et al.
Publicado: (2020)

Ventricular arrhythmias among patients with implantable cardioverter‐defibrillator during the COVID‐19 pandemic
por: Malanchini, G., et al.
Publicado: (2021)

Effects of COVID‐19 lockdown on arrhythmias in patients with implantable cardioverter‐defibrillators in southern Italy
por: Ducceschi, Valentino, et al.
Publicado: (2022)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Heart age gap estimated by explainable advanced electrocardiography is associated with cardiovascular risk factors and survival
por: Lindow, Thomas, et al.
Publicado: (2023)

Predictive value of gamma-glutamyltransferase for ventricular arrhythmias and cardiovascular mortality in implantable cardioverter-defibrillator patients
por: Zhou, You, et al.
Publicado: (2019)

Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
por: Noordman, Alwin B. P., et al.
Publicado: (2021)

Sex‐specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patients
por: van der Lingen, Anne‐Lotte C.J., et al.
Publicado: (2021)

Predictors of Mortality Amongst Recipients of Implantable Cardioverter Defibrillators for Secondary Prevention of Cardiac Arrest
por: Agarwal, Sunil K, et al.
Publicado: (2007)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Predictors of early mortality in implantable cardioverter-defibrillator recipients
por: Stein, Kenneth M., et al.
Publicado: (2009)

Implantable cardioverter-defibrillator (ICD) provides an exclusive epidemiological tool for evaluation of the earthquake induced cardiac arrhythmias
por: Ranjbar, Abdolmohammad, et al.
Publicado: (2017)

Comorbid Hypertension Reduces the Risk of Ventricular Arrhythmia in Chronic Heart Failure Patients with Implantable Cardioverter-Defibrillators
por: Huang, Hao, et al.
Publicado: (2022)

Ventricular tachycardia as presenting arrhythmia as a determinant of appropriate implantable cardioverter-defibrillator therapy in secondary prevention
por: Noordman, A B P, et al.
Publicado: (2023)

Successful defibrillation verification in subcutaneous implantable cardioverter‐defibrillator recipients by low‐energy shocks
por: Biffi, Mauro, et al.
Publicado: (2019)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

The association between defibrillation shock energy and acute cardiac damage in patients with implantable cardioverter defibrillators
por: Ishigaki, Daisuke, et al.
Publicado: (2016)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

Chronic Kidney Disease and Mortality in Implantable Cardioverter-Defibrillator Recipients
por: Cheema, Aamir, et al.
Publicado: (2010)

Arrhythmic triad in an implantable cardioverter‐defibrillator recipient with severe hypokalemia
por: Ciriello, Giovanni Domenico, et al.
Publicado: (2022)

Main air pollutants and ventricular arrhythmias in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis
por: Yang, Hong-Jie, et al.
Publicado: (2017)

Implantable cardioverter defibrillator as a treatment for massive left ventricular fibroma-induced ventricular arrhythmia in a child
por: Choi, In Su, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p1ka3gpnp6mgg8fqsl7jcrd6s8